Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology

Clinical trial NCT06856525 · RECRUITING

Trial details

NCT number: NCT06856525
Sponsor: Y. Michael Shim, MD
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Electronic Cigarette Related Lung Damage

Start date: 2024-12-19
Primary completion: 2028-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.